CRED, a leading Egyptian pharmaceutical company, has recently launched a new compound called Ever. This innovative product is a combination of two active ingredients, which work together to provide effective relief from pain and inflammation.

The first active ingredient in Ever is diclofenac, a non-steroidal anti-inflammatory drug (NSAID) that is commonly used to treat pain and inflammation. The second active ingredient is methyl salicylate, which is a topical analgesic that is often used to relieve muscle and joint pain.

By combining these two ingredients, Ever provides a powerful and fast-acting solution for a wide range of pain and inflammation-related conditions. These may include arthritis, back pain, sprains, strains, and other musculoskeletal injuries.

One of the key benefits of Ever is its targeted delivery system. The compound is designed to be absorbed directly through the skin and into the affected area, where it can provide fast and effective relief. This targeted delivery system also helps to minimize the risk of side effects, as the medication is not absorbed into the bloodstream.

In addition to its pain-relieving properties, Ever also has anti-inflammatory effects. This means that it can help to reduce swelling and inflammation in the affected area, which can further improve pain